Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1155520180130010023
Anesthesia and Pain Medicine
2018 Volume.13 No. 1 p.23 ~ p.29
Pre-anesthetic sedative effect of dexmedetomidine in laparoscopic cholecystectomy performed under general anesthesia
Kim Jae-Won

Lee Hye-Lim
Park Joo-Seung
Kim Ji-Hoon
Ryu Keon-Hee
Abstract
Background: This study evaluated the effects of pre-anesthetic administration of dexmedetomidine on sedative, cardiovascular, and recovery parameters.

Methods: This was a prospective, randomized, double-blind, placebo-controlled study. We selected 60 patients who were scheduled to undergo laparoscopic cholecystectomy. They were randomly divided into two groups and received 0.5 ¥ìg/kg of dexmedetomidine (group D) or normal saline (group S) over 10 minutes before induction of anesthesia. The Ramsay sedation scale (RSS) score and bispectral index (BIS) were recorded after completion of the dexmedetomidine infusion. Mean arterial pressure (MAP), heart rate (HR), peripheral pulse oximetry, cardiac output (CO), and systemic vascular resistance (SVR) were recorded. The modified Aldrete recovery score (MARS) was recorded in the recovery room.

Results: After completion of the dexmedetomidine infusion, BIS reduction was less than 20% (97.1 ¡¾ 2.4, 83.8 ¡¾ 4.8; P < 0.001), but RSS-rated sedation was appropriate (P < 0.001). HR was lowest at the end of the dexmedetomidine infusion and there was a significant difference between groups (P < 0.001); however, MAP was not significantly different between groups (P = 0.139). CO was lowest and SVR was highest at the end of the dexmedetomidine infusion. There was no significant difference in MARS values between groups (P = 0.190).

Conclusions: A pre-anesthetic dexmedetomidine (0.5 ¥ìg/kg) provided appropriate sedation without serious changes in cardiovascular parameters or a prolonged recovery time.
KEYWORD
Dexmedetomidine, Laparoscopic cholecystectomy, Moderate sedation
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø